Drugs / Grippol Plus
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT06385821 Comparator | Sep 2022 → Jun 2023 | swine influenza | NPO Petrovax | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Grippol Plus | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06385821 ↗ |
| Modality | Vaccine | “influenza trivalent inactivated polymer-subunit vaccine” NCT06385821 ↗ |
| Route | Intramuscular | “Suspension for intramuscular and subcutaneous administration” NCT06385821 ↗ |
| Route | Subcutaneous | “Suspension for intramuscular and subcutaneous administration” NCT06385821 ↗ |